Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Loegering

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biomedical Chromatography : BMC|April 30, 2003
A modular on-line three-dimensional liquid chromatography-tandem mass spectrometry approach to characterization of organelle proteomesKenneth L Johnson, David A Loegering, Gerald J Gleich, et al.
Molecular Pharmacology|February 27, 2014
Context-dependent antagonism between Akt inhibitors and topoisomerase poisonsMarina Gálvez-Peralta, Karen S Flatten, David A Loegering, et al.
Journal of Immunological Methods|November 1, 2005
Differential extraction of eosinophil granule proteinsLyo E Ohnuki, Lori A Wagner, Ann Georgelas, et al.
The Journal of Biological Chemistry|April 15, 2008
Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase IJennifer S Hackbarth, Marina Galvez-Peralta, Nga T Dai, et al.
Methods (San Diego, Calif.)|March 4, 2008
Apoptosis-associated caspase activation assaysScott H Kaufmann, Sun-Hee Lee, X Wei Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Major basic protein homolog (MBP2): a specific human eosinophil markerDouglas A Plager, David A Loegering, James L Checkel, et al.
Molecular Pharmacology|May 30, 2008
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell linesMarina Gálvez-Peralta, Nga T Dai, David A Loegering, et al.
Cancer Research|October 1, 2009
Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitroAndrea E Wahner Hendrickson, Paul Haluska, Paula A Schneider, et al.
Cancer Research|January 7, 2006
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417Paul Haluska, Joan M Carboni, David A Loegering, et al.
Blood|January 15, 2005
Proteomic analysis of mantle-cell lymphoma by protein microarrayIrene M Ghobrial, Daniel J McCormick, Scott H Kaufmann, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biomedical Chromatography : BMC|April 30, 2003
A modular on-line three-dimensional liquid chromatography-tandem mass spectrometry approach to characterization of organelle proteomesKenneth L Johnson, David A Loegering, Gerald J Gleich, et al.
Molecular Pharmacology|February 27, 2014
Context-dependent antagonism between Akt inhibitors and topoisomerase poisonsMarina Gálvez-Peralta, Karen S Flatten, David A Loegering, et al.
Journal of Immunological Methods|November 1, 2005
Differential extraction of eosinophil granule proteinsLyo E Ohnuki, Lori A Wagner, Ann Georgelas, et al.
The Journal of Biological Chemistry|April 15, 2008
Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase IJennifer S Hackbarth, Marina Galvez-Peralta, Nga T Dai, et al.
Methods (San Diego, Calif.)|March 4, 2008
Apoptosis-associated caspase activation assaysScott H Kaufmann, Sun-Hee Lee, X Wei Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Major basic protein homolog (MBP2): a specific human eosinophil markerDouglas A Plager, David A Loegering, James L Checkel, et al.
Molecular Pharmacology|May 30, 2008
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell linesMarina Gálvez-Peralta, Nga T Dai, David A Loegering, et al.
Cancer Research|October 1, 2009
Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitroAndrea E Wahner Hendrickson, Paul Haluska, Paula A Schneider, et al.
Cancer Research|January 7, 2006
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417Paul Haluska, Joan M Carboni, David A Loegering, et al.
Blood|January 15, 2005
Proteomic analysis of mantle-cell lymphoma by protein microarrayIrene M Ghobrial, Daniel J McCormick, Scott H Kaufmann, et al.
Pageof 2